Tara brings a deep clinical background, a passion for developing and commercializing medical technologies, and the unique perspective that comes from her venture capital role representing healthcare providers in partnership with Ascension to the BOD.
As a Managing Director at Ascension Ventures investing in medical devices for almost 20 years, she currently sits on the board of Instylla, Imperative Care, Rejoni, NeuroLutions, Renovia, Ivantis, Cardionomic, and CSA Medical. Tara was previously a board member or observer at Apama Medical (acquired by Boston Scientific), Augmenix (acquired by Boston Scientific), Novasys (acquired by Verathon Medical), CHF Solutions (acquired by Gambro), Confluent Surgical (acquired by Tyco), Ekos (acquired by BTG), HemoSphere (acquired by CryoLife), Ocular Therapeutix (NASD: OCUL), Stereotaxis (NASD: STXS), MindFrame (acquired by Boston Scientific), TomoTherapy (NASD:TOMO), and EBR Systems. Prior to Ascension Ventures, Tara completed her residency in Obstetrics and Gynecology at the Washington University in St. Louis. She previously held positions in business development at Medtronic and finance at Honeywell.
She holds a BS in Economics and an MBA from the Wharton School of Business at the University of Pennsylvania, and an MD from the University of Pennsylvania.
This person is not in the org chart